With Bumper $33B Sales, Novo Nordisk Forecasts Double-Digit 2024 Earnings Growth, Boosts Lower Dose Wegovy US Supplies

With Bumper $33B Sales, Novo Nordisk Forecasts Double-Digit 2024 Earnings Growth, Boosts Lower Dose Wegovy US Supplies

Upworthy

Published

Novo Nordisk A/S NVO on Wednesday reported fourth quarter of 2023 sales of DKK 65.86 billion ($9.5 billion compared to the consensus of $8.82 billion), up 37% measured in Danish kroner and 43% at CER compared to 2022. Diabetes and Obesity care sales of DKK 61.29 billion drove the global sales…

#novonordiskasnvo #dkk6586billion #danish #cer #dkk #glp1 #wegovy #yyozempic #novonordisk #priceactionnvo

Full Article